16-18 Mai 2022
\nMilan, Italie<\/p>\n
ENYO Pharma participera \u00e0 la 22e \u00e9dition de Bio\u20acquity Europe, l\u2019\u00e9v\u00e8nement international en Europe pour les investisseurs et les dirigeants de l\u2019industrie biopharmaceutique, qui y rencontreront des entreprises de biotechnologie en plein essor.
\nL\u2019\u00e9quipe d\u2019ENYO Pharma reprend contact avec les investisseurs et partenaires potentiels afin d\u2019acc\u00e9l\u00e9rer le d\u00e9veloppement clinique de son compos\u00e9 principal Vonafexor ax\u00e9 sur les maladies r\u00e9nales et h\u00e9patiques. Jacky Vonderscher pr\u00e9sentera \u00e9galement \u201cVONAFEXOR, a fibrolytic and anti-inflammatory for the treatment of kidney and liver diseases\u201d lors de la session Hot Topics Track #1, 16h30-16h42, le 17 mai 2022<\/p>\n
https:\/\/conferences.biocentury.com\/bioequity-europe<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" 16-18 Mai 2022 ENYO Pharma participera \u00e0 la 22e \u00e9dition de Bio\u20acquity Europe, l\u2019\u00e9v\u00e8nement international en Europe pour les investisseurs et les dirigeants de l\u2019industrie biopharmaceutique, qui y rencontreront des entreprises de biotechnologie en plein essor. Lire la suite »<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[12],"tags":[],"class_list":["post-4110","post","type-post","status-publish","format-standard","hentry","category-events-fr"],"acf":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","rttpg_featured_image_url":null,"rttpg_author":{"display_name":"editorENYOPharma","author_link":"https:\/\/www.enyopharma.com\/fr\/author\/editorenyopharma\/"},"rttpg_comment":0,"rttpg_category":"\u00c9v\u00e9nements<\/a>","rttpg_excerpt":"16-18 Mai 2022 Milan, Italie ENYO Pharma participera \u00e0 la 22e \u00e9dition de Bio\u20acquity Europe, l\u2019\u00e9v\u00e8nement international en Europe pour les investisseurs et les dirigeants de l\u2019industrie biopharmaceutique, qui y rencontreront des entreprises de biotechnologie en plein essor. L\u2019\u00e9quipe d\u2019ENYO Pharma reprend contact avec les investisseurs et partenaires potentiels afin d\u2019acc\u00e9l\u00e9rer le d\u00e9veloppement clinique de…","_links":{"self":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/4110","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/comments?post=4110"}],"version-history":[{"count":2,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/4110\/revisions"}],"predecessor-version":[{"id":4112,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/4110\/revisions\/4112"}],"wp:attachment":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/media?parent=4110"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/categories?post=4110"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/tags?post=4110"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nMilan, Italie<\/p>\n
\nL\u2019\u00e9quipe d\u2019ENYO Pharma reprend contact avec les investisseurs et partenaires potentiels afin d\u2019acc\u00e9l\u00e9rer le d\u00e9veloppement clinique de son compos\u00e9 principal Vonafexor ax\u00e9 sur les maladies r\u00e9nales et h\u00e9patiques. Jacky Vonderscher pr\u00e9sentera \u00e9galement \u201cVONAFEXOR,<\/p>\n